June 19, 2020 / 1:34 PM / a month ago

BRIEF-Nymox Updates Regulatory Submissions For Fexapotide Treatment For Prostate Enlargement

June 19 (Reuters) - Nymox Pharmaceutical Corp:

* NYMOX ANNOUNCES UPDATES IN REGULATORY SUBMISSIONS FOR FEXAPOTIDE TREATMENT FOR PROSTATE ENLARGEMENT

* NYMOX PHARMACEUTICAL - CERTAIN TASKS HAVE BEEN HAMPERED BY COVID PANDEMIC RESTRICTIONS

* NYMOX PHARMACEUTICAL - NOW EXPECTING TO FILE APPLICATIONS WITH AUTHORITIES ABOUT BY END OF Q3 OR EARLY Q4 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below